# Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma

> **NCT00687622** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 206 (actual)

## Conditions studied

- Solid Tumours

## Interventions

- **DRUG:** GSK1120212

## Key facts

- **NCT ID:** NCT00687622
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07-28
- **Primary completion:** 2011-06-07
- **Final completion:** 2011-11-08
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2017-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00687622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00687622, "Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00687622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*